CanSino Biologics Inc. (OTCMKTS:CASBF) Short Interest Update

CanSino Biologics Inc. (OTCMKTS:CASBF) saw a large drop in short interest in September. As of September 15th, there was short interest totaling 83,640 shares, a drop of 82.8% from the August 31st total of 485,040 shares. Based on an average daily trading volume, of 7 shares, the days-to-cover ratio is currently 11,948.6 days.

CanSino Biologics Price Performance

Shares of OTCMKTS CASBF opened at C$2.95 on Friday. The firm’s 50-day moving average price is C$3.61 and its 200-day moving average price is C$3.52. CanSino Biologics has a 52-week low of C$2.60 and a 52-week high of C$6.99.

CanSino Biologics Company Profile

CanSino Biologics Inc is a China-based biopharmaceutical company focused on the research, development, manufacturing and commercialization of vaccines. The company develops vaccine technologies for infectious diseases and seeks to provide products for both public-health programs and commercial markets.

CanSino’s portfolio includes Convidecia, an adenovirus-vector COVID-19 vaccine, as well as an inhaled formulation known as Convidecia Air. The company has also worked on vaccines targeting meningococcal disease and other infectious conditions, using platforms that include viral vectors, conjugate vaccines and recombinant protein technologies.

Founded in 2009 and headquartered in Tianjin, China, CanSino has built its operations around domestic vaccine development and manufacturing while pursuing international collaboration and market opportunities.